Carrel name: journal-jEurAcadDermatolVenereol-cord Creating study carrel named journal-jEurAcadDermatolVenereol-cord Initializing database file: cache/cord-266475-t04pukea.json key: cord-266475-t04pukea authors: Balestri, R.; Termine, S.; Rech, G.; Girardelli, C.R. title: Late onset of acral necrosis after SARS‐CoV‐2 infection resolution date: 2020-05-26 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16668 sha: doc_id: 266475 cord_uid: t04pukea file: cache/cord-260218-add4i1c9.json key: cord-260218-add4i1c9 authors: Bosch‐Amate, X; Giavedoni, P; Podlipnik, S; Andreu‐Febrer, C; Sanz‐Beltran, J; Garcia‐Herrera, A; Alós, L; Mascaró, JM title: Retiform purpura as a dermatological sign of covid‐19 coagulopathy date: 2020-06-03 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16689 sha: doc_id: 260218 cord_uid: add4i1c9 file: cache/cord-258581-46p0k9lc.json key: cord-258581-46p0k9lc authors: Bodak, Nathalie; Chiaverini, Christine; Barbarot, Sebastien title: COVID‐19 Lockdown induced acral dermatosis in children date: 2020-06-28 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16797 sha: doc_id: 258581 cord_uid: 46p0k9lc file: cache/cord-283716-tleh9323.json key: cord-283716-tleh9323 authors: Amatore, F.; Macagno, N.; Mailhe, M.; Demarez, B.; Gaudy‐Marqueste, C.; Grob, J.J.; Raoult, D.; Brouqui, P.; Richard, M.A. title: SARS‐CoV‐2 infection presenting as a febrile rash date: 2020-05-27 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16528 sha: doc_id: 283716 cord_uid: tleh9323 file: cache/cord-326737-b6gs9z4h.json key: cord-326737-b6gs9z4h authors: Balestri, R.; Magnano, M.; Rizzoli, L.; Infusino, S.D.; Urbani, F.; Rech, G. title: STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections date: 2020-07-27 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16808 sha: doc_id: 326737 cord_uid: b6gs9z4h file: cache/cord-252123-z8c14q5d.json key: cord-252123-z8c14q5d authors: Negrini, S.; Guadagno, A.; Greco, M.; Parodi, A.; Burlando, M. title: An unusual case of bullous hemorrhagic vasculitis in a COVID‐19 patient date: 2020-06-19 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16760 sha: doc_id: 252123 cord_uid: z8c14q5d file: cache/cord-282653-9n5sjn23.json key: cord-282653-9n5sjn23 authors: Rodríguez‐Jiménez, Pedro; Chicharro, Pablo; De Argila, Diego; Muñoz‐Hernández, Patricia; Llamas‐Velasco, Mar title: Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection”: Urticaria‐like lesions in COVID‐19 patients are not really urticaria. A case with clinicopathologic correlation date: 2020-05-09 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16618 sha: doc_id: 282653 cord_uid: 9n5sjn23 file: cache/cord-309507-oe4i6v5x.json key: cord-309507-oe4i6v5x authors: Sacchelli, L.; Viviani, F.; Orioni, G.; Rucci, P.; Rosa, S.; Lanzoni, A.; Patrizi, A.; Gaspari, V. title: Sexually Transmitted Infections during the COVID‐19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice date: 2020-06-03 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16694 sha: doc_id: 309507 cord_uid: oe4i6v5x file: cache/cord-277110-e27lm7rr.json key: cord-277110-e27lm7rr authors: Iria, Neri; Annalucia, Virdi; Ilaria, Corsini; Alba, Guglielmo; Tiziana, Lazzarotto; Liliana, Gabrielli; Cosimo, Misciali; Annalisa, Patrizi; Marcello, Lanari title: Major cluster of pediatric “ true ” primary chilblains during the COVID‐19 pandemic: a consequence of lifestyle changes due to lockdown date: 2020-06-13 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16751 sha: doc_id: 277110 cord_uid: e27lm7rr file: cache/cord-301483-dsaltzdd.json key: cord-301483-dsaltzdd authors: Hashizume, H.; Sano, Y.; Furukawa, S.; Imokawa, S. title: Eosinophilic granulomatosis with polyangiitis mimicking COVID‐19: a case report date: 2020-06-04 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16705 sha: doc_id: 301483 cord_uid: dsaltzdd file: cache/cord-295551-ujnks5ox.json key: cord-295551-ujnks5ox authors: Estébanez, Andrea; Pérez‐Santiago, Leticia; Silva, Esmeralda; Guillen‐Climent, Santiago; García‐Vázquez, Alejandro; Ramón, M. Dolores title: Cutaneous manifestations in COVID‐19: a new contribution date: 2020-04-15 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16474 sha: doc_id: 295551 cord_uid: ujnks5ox file: cache/cord-272321-znnipzym.json key: cord-272321-znnipzym authors: Verheyden, M.; Grosber, M.; Gutermuth, J.; Velkeniers, B. title: Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection date: 2020-06-25 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16773 sha: doc_id: 272321 cord_uid: znnipzym file: cache/cord-310841-scg0h40b.json key: cord-310841-scg0h40b authors: Atzori, L.; Mugheddu, C.; Addis, G.; Sanna, S.; Satta, R.; Ferreli, C.; Atzori, M.G.; Montesu, M.A.; Rongioletti, F. title: Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) date: 2020-04-15 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16473 sha: doc_id: 310841 cord_uid: scg0h40b file: cache/cord-339195-aq3hb68r.json key: cord-339195-aq3hb68r authors: Falkenhain‐López, D.; Agud‐Dios, M.; Ortiz‐Romero, P.L.; Sánchez‐Velázquez, A. title: COVID‐19‐related acute genital ulcers date: 2020-06-26 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16740 sha: doc_id: 339195 cord_uid: aq3hb68r file: cache/cord-270500-5pkx94zu.json key: cord-270500-5pkx94zu authors: Duong, T.A.; Velter, C.; Rybojad, M.; Comte, C.; Bagot, M.; Sulimovic, L.; Bouaziz, J.D. title: Did Whatsapp(®) reveal a new cutaneous COVID‐19 manifestation? date: 2020-05-19 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16534 sha: doc_id: 270500 cord_uid: 5pkx94zu file: cache/cord-341118-h5t87vf8.json key: cord-341118-h5t87vf8 authors: Torres‐Navarro, Ignacio; Abril‐Pérez, Carlos; Roca‐Ginés, Juncal; Sánchez‐Arráez, Javier; Botella‐Estrada, Rafael title: A case of cefditoren‐induced Acute Generalized Exanthematous Pustulosis during COVID‐19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue date: 2020-05-26 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16664 sha: doc_id: 341118 cord_uid: h5t87vf8 file: cache/cord-314422-u2elzgl8.json key: cord-314422-u2elzgl8 authors: Bothra, Atul; Das, Seujee; Singh, Mehak; Pawar, Manoj; Maheswari, Anshu title: Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic date: 2020-06-03 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16692 sha: doc_id: 314422 cord_uid: u2elzgl8 file: cache/cord-327036-0260rrdx.json key: cord-327036-0260rrdx authors: Dominguez‐Santas, M.; Diaz‐Guimaraens, B.; Garcia Abellas, P.; Moreno‐Garcia del Real, C.; Burgos‐Blascoª, P.; Suarez‐Valle, A. title: Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19) date: 2020-05-26 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16663 sha: doc_id: 327036 cord_uid: 0260rrdx file: cache/cord-304946-fs02dxg5.json key: cord-304946-fs02dxg5 authors: Brochez, L.; Baurain, J.F.; Del Marmol, V.; Nikkels, A.; Kruse, V.; Sales, F.; Stas, M.; Van Laethem, A.; Garmyn, M. title: Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic date: 2020-08-12 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16772 sha: doc_id: 304946 cord_uid: fs02dxg5 file: cache/cord-344273-uztk6pc0.json key: cord-344273-uztk6pc0 authors: Tejera‐Vaquerizo, Antonio; Nagore, Eduardo title: Estimated effect of COVID‐19 lockdown on melanoma thickness and prognosis: a rate of growth model date: 2020-05-02 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16555 sha: doc_id: 344273 cord_uid: uztk6pc0 file: cache/cord-299143-vcfu79ij.json key: cord-299143-vcfu79ij authors: McCoy, John; Wambier, Carlos Gustavo; Herrera, Sabina; Vaño‐Galván, Sergio; Gioia, Francesca; Comeche, Belen; Ron, Raquel; Serrano‐Villar, Sergio; Iwasiow, Rafal M; Tayeb, Michael A; Cadegiani, Flávio Adsuara; Mesinkovska, Natasha Atanaskova; Shapiro, Jerry; Sinclair, Rodney; Goren, Andy title: Androgen Receptor Genetic Variant Predicts COVID‐19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID‐19 Male Patients date: 2020-09-25 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16956 sha: doc_id: 299143 cord_uid: vcfu79ij file: cache/cord-304211-5uzqqbr4.json key: cord-304211-5uzqqbr4 authors: Tammaro, A.; Adebanjo, G.A.R.; Parisella, F.R.; Pezzuto, A.; Rello, J. title: Cutaneous manifestations in COVID‐19: the experiences of Barcelona and Rome date: 2020-04-24 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16530 sha: doc_id: 304211 cord_uid: 5uzqqbr4 file: cache/cord-300995-tqz2bkdo.json key: cord-300995-tqz2bkdo authors: Tagliaferri, Luca; Di Stefani, Alessandro; Schinzari, Giovanni; Fionda, Bruno; Rossi, Ernesto; Del Regno, Laura; Gentileschi, Stefano; Federico, Francesco; Valentini, Vincenzo; Tortora, Giampaolo; Peris, Ketty title: Skin cancer triage and management during COVID‐19 pandemic date: 2020-04-25 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16529 sha: doc_id: 300995 cord_uid: tqz2bkdo file: cache/cord-282750-d9sb7o63.json key: cord-282750-d9sb7o63 authors: Benhadou, F.; Del Marmol, V. title: Improvement of SARS‐CoV2 symptoms following Guselkumab injection in a psoriatic patient date: 2020-05-07 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16590 sha: doc_id: 282750 cord_uid: d9sb7o63 file: cache/cord-253552-qreg4emx.json key: cord-253552-qreg4emx authors: Bouaziz, JD; Duong, T; Jachiet, M; Velter, C; Lestang, P; Cassius, C; Arsouze, A; Domergue Than Trong, E; Bagot, M; Begon, E; Sulimovic, L; Rybojad, M title: Vascular skin symptoms in COVID‐19: a french observational study date: 2020-04-27 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16544 sha: doc_id: 253552 cord_uid: qreg4emx file: cache/cord-281703-6xwcxe8l.json key: cord-281703-6xwcxe8l authors: Di Altobrando, Ambra; Patrizi, Annalisa; Bardazzi, Federico title: Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases? date: 2020-04-17 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16491 sha: doc_id: 281703 cord_uid: 6xwcxe8l file: cache/cord-303514-2ljmkabk.json key: cord-303514-2ljmkabk authors: Recalcati, S.; Barbagallo, T.; Frasin, L.A.; Prestinari, F.; Cogliardi, A.; Provero, M.C.; Dainese, E.; Vanzati, A.; Fantini, F. title: Acral cutaneous lesions in the time of COVID‐19 date: 2020-05-27 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16533 sha: doc_id: 303514 cord_uid: 2ljmkabk file: cache/cord-311523-erntrh3p.json key: cord-311523-erntrh3p authors: Gisondi, P; Piaserico, S; Conti, A; Naldi, L title: Dermatologists and SARS‐CoV‐2: The impact of the pandemic on daily practice date: 2020-04-22 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16515 sha: doc_id: 311523 cord_uid: erntrh3p file: cache/cord-323334-ie7iklr4.json key: cord-323334-ie7iklr4 authors: Tartari, F; Guglielmo, A; Fuligni, F; Pileri, A title: Changes in emergency service access after spread of COVID19 across Italy date: 2020-04-27 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16553 sha: doc_id: 323334 cord_uid: ie7iklr4 file: cache/cord-341999-nosdj7b2.json key: cord-341999-nosdj7b2 authors: Conti, A.; Lasagni, C.; Bigi, L.; Pellacani, G. title: Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs date: 2020-05-07 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16587 sha: doc_id: 341999 cord_uid: nosdj7b2 file: cache/cord-267748-uzt8a5nx.json key: cord-267748-uzt8a5nx authors: Shiohara, Tetsuo; Mizukawa, Yoshiko title: Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 date: 2020-09-24 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16959 sha: doc_id: 267748 cord_uid: uzt8a5nx file: cache/cord-290146-7fz9bj0b.json key: cord-290146-7fz9bj0b authors: Ring, J. title: COVID‐19 and its implications for Dermatology and Venereology date: 2020-05-22 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16414 sha: doc_id: 290146 cord_uid: 7fz9bj0b file: cache/cord-340842-s00465sy.json key: cord-340842-s00465sy authors: Cabrera‐Hernández, R.; Solano‐Solares, E.; Chica‐Guzmán, V.; Fernández‐Guarino, M.; Fernández‐Nieto, D.; Ortega‐Quijano, D.; de‐Andrés‐Martín, A.; Moreno, C.; Carretero‐Barrio, I.; García‐Abellás, P.; González‐de‐Olano, D.; de‐la‐Hoz‐Caballer, B. title: SARS‐CoV‐2, skin lesions and the need of a multidisciplinary approach date: 2020-06-13 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16745 sha: doc_id: 340842 cord_uid: s00465sy file: cache/cord-342254-vdovpfu1.json key: cord-342254-vdovpfu1 authors: Mugheddu, C.; Pizzatti, L.; Sanna, S.; Atzori, L.; Rongioletti, F. title: CID‐19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management date: 2020-06-04 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16625 sha: doc_id: 342254 cord_uid: vdovpfu1 file: cache/cord-345514-71qgingu.json key: cord-345514-71qgingu authors: Najafzadeh, Mojgan; Shahzad, Fanila; Ghaderi, Nader; Ansari, Kaveh; Jacob, Badie; Wright, Andrew title: Urticaria (angioedema) and COVID‐ 19 infection date: 2020-06-11 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16721 sha: doc_id: 345514 cord_uid: 71qgingu file: cache/cord-346017-wforwxes.json key: cord-346017-wforwxes authors: Kasperkiewicz, M.; Schmidt, E.; Fairley, J.A.; Joly, P.; Payne, A.S.; Yale, M.L.; Zillikens, D.; Woodley, D.T. title: Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic date: 2020-04-25 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16525 sha: doc_id: 346017 cord_uid: wforwxes file: cache/cord-346763-xdfl659q.json key: cord-346763-xdfl659q authors: Herman, A.; Matthews, M.; Mairlot, M.; Nobile, L.; Fameree, L.; Jacquet, L.‐M.; Baeck, M. title: Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19 date: 2020-08-13 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16838 sha: doc_id: 346763 cord_uid: xdfl659q file: cache/cord-300546-s29ycc8i.json key: cord-300546-s29ycc8i authors: Balestri, R.; Rech, G.; Girardelli, C.R. title: Occurrence of SARS‐CoV‐2 during mycophenolate mofetil treatment for pemphigus date: 2020-05-02 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16578 sha: doc_id: 300546 cord_uid: s29ycc8i file: cache/cord-322069-ys9s7l6e.json key: cord-322069-ys9s7l6e authors: Gaspari, Valeria; Neri, Iria; Misciali, Cosimo; Patrizi, Annalisa title: COVID‐19: how it can look on the skin. Clinical and pathological features in twenty COVID‐19 patients observed in Bologna, northeastern Italy date: 2020-06-03 journal: J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.16693 sha: doc_id: 322069 cord_uid: ys9s7l6e Reading metadata file and updating bibliogrpahics === updating bibliographic database Building study carrel named journal-jEurAcadDermatolVenereol-cord === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60720 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 58833 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 59091 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 59450 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60562 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60543 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 61283 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60568 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 61155 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 61130 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60666 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60656 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 62910 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60958 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60872 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 61023 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60678 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60674 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 62197 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60725 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 62403 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60698 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60788 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 60706 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 62155 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 61737 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 62805 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 62775 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === OMP: Error #34: System unable to allocate necessary resources for OMP thread: OMP: System error #11: Resource temporarily unavailable OMP: Hint Try decreasing the value of OMP_NUM_THREADS. /data-disk/reader-compute/reader-cord/bin/file2bib.sh: line 39: 62474 Aborted $FILE2BIB "$FILE" > "$OUTPUT" === file2bib.sh === id: cord-327036-0260rrdx author: Dominguez‐Santas, M. title: Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19) date: 2020-05-26 pages: extension: .txt txt: ./txt/cord-327036-0260rrdx.txt cache: ./cache/cord-327036-0260rrdx.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 2 resourceName b'cord-327036-0260rrdx.txt' === file2bib.sh === id: cord-282653-9n5sjn23 author: Rodríguez‐Jiménez, Pedro title: Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection”: Urticaria‐like lesions in COVID‐19 patients are not really urticaria. A case with clinicopathologic correlation date: 2020-05-09 pages: extension: .txt txt: ./txt/cord-282653-9n5sjn23.txt cache: ./cache/cord-282653-9n5sjn23.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 2 resourceName b'cord-282653-9n5sjn23.txt' === file2bib.sh === id: cord-260218-add4i1c9 author: Bosch‐Amate, X title: Retiform purpura as a dermatological sign of covid‐19 coagulopathy date: 2020-06-03 pages: extension: .txt txt: ./txt/cord-260218-add4i1c9.txt cache: ./cache/cord-260218-add4i1c9.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 2 resourceName b'cord-260218-add4i1c9.txt' === file2bib.sh === id: cord-258581-46p0k9lc author: Bodak, Nathalie title: COVID‐19 Lockdown induced acral dermatosis in children date: 2020-06-28 pages: extension: .txt txt: ./txt/cord-258581-46p0k9lc.txt cache: ./cache/cord-258581-46p0k9lc.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 1 resourceName b'cord-258581-46p0k9lc.txt' === file2bib.sh === id: cord-341999-nosdj7b2 author: Conti, A. title: Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs date: 2020-05-07 pages: extension: .txt txt: ./txt/cord-341999-nosdj7b2.txt cache: ./cache/cord-341999-nosdj7b2.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 1 resourceName b'cord-341999-nosdj7b2.txt' === file2bib.sh === id: cord-283716-tleh9323 author: Amatore, F. title: SARS‐CoV‐2 infection presenting as a febrile rash date: 2020-05-27 pages: extension: .txt txt: ./txt/cord-283716-tleh9323.txt cache: ./cache/cord-283716-tleh9323.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 3 resourceName b'cord-283716-tleh9323.txt' === file2bib.sh === id: cord-309507-oe4i6v5x author: Sacchelli, L. title: Sexually Transmitted Infections during the COVID‐19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice date: 2020-06-03 pages: extension: .txt txt: ./txt/cord-309507-oe4i6v5x.txt cache: ./cache/cord-309507-oe4i6v5x.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 1 resourceName b'cord-309507-oe4i6v5x.txt' === file2bib.sh === id: cord-339195-aq3hb68r author: Falkenhain‐López, D. title: COVID‐19‐related acute genital ulcers date: 2020-06-26 pages: extension: .txt txt: ./txt/cord-339195-aq3hb68r.txt cache: ./cache/cord-339195-aq3hb68r.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 2 resourceName b'cord-339195-aq3hb68r.txt' === file2bib.sh === id: cord-326737-b6gs9z4h author: Balestri, R. title: STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections date: 2020-07-27 pages: extension: .txt txt: ./txt/cord-326737-b6gs9z4h.txt cache: ./cache/cord-326737-b6gs9z4h.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 2 resourceName b'cord-326737-b6gs9z4h.txt' === file2bib.sh === id: cord-267748-uzt8a5nx author: Shiohara, Tetsuo title: Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 date: 2020-09-24 pages: extension: .txt txt: ./txt/cord-267748-uzt8a5nx.txt cache: ./cache/cord-267748-uzt8a5nx.txt Content-Encoding UTF-8 Content-Type text/plain; charset=UTF-8 X-Parsed-By ['org.apache.tika.parser.DefaultParser', 'org.apache.tika.parser.csv.TextAndCSVParser'] X-TIKA:content_handler ToTextContentHandler X-TIKA:embedded_depth 0 X-TIKA:parse_time_millis 2 resourceName b'cord-267748-uzt8a5nx.txt' Que is empty; done journal-jEurAcadDermatolVenereol-cord === reduce.pl bib === === reduce.pl bib === id = cord-258581-46p0k9lc author = Bodak, Nathalie title = COVID‐19 Lockdown induced acral dermatosis in children date = 2020-06-28 pages = extension = .txt mime = text/plain words = 557 sentences = 36 flesch = 55 summary = Recently, several case series of cutaneous acral manifestations in patients with suspected or confirmed coronavirus disease 2019 (COVID‐19) have been reported. Indirect consequences of the ongoing pandemic on skin health have been reported, such as an increased frequency of irritant dermatitis related to repeated hand washing with soap, or occupational dermatoses in health care workers due to wearing gloves or masks (4, 5) . We describe here acral lesions observed in seven children (four girls) by the sixth week of the lockdown period in France. Although a larger case series would strengthen our hypothesis, we suggest that the change of daily habits in young children during the lockdown period may have increased the frequency of acral frictional dermatoses that are not directly due to the virus but rather to prolonged sessions spent playing on the floor. Acral cutaneous lesions in the Time of COVID-19 cache = ./cache/cord-258581-46p0k9lc.txt txt = ./txt/cord-258581-46p0k9lc.txt === reduce.pl bib === id = cord-260218-add4i1c9 author = Bosch‐Amate, X title = Retiform purpura as a dermatological sign of covid‐19 coagulopathy date = 2020-06-03 pages = extension = .txt mime = text/plain words = 448 sentences = 36 flesch = 43 summary = Recalcati(1) asserted that 20.4% of infected patients developed cutaneous manifestations and Galván‐Casas et al(2) have recently proposed 5 clinical patterns (pseudo‐chilblain, vesicular, urticarial, maculopapular and livedo/necrosis). 6 Purpura, Raynaud's phenomenon, chilblain-like and erythema multiforme-like lesions in young asymptomatic patients have also been observed with this infection, although the connection with coagulopathy is unknown. 7, 8 Our patient presented with retiform purpura as a cutaneous manifestation of COVID-19 coagulopathy. 9 Our case highlights the concomitant presentation of cutaneous microthrombi presenting as retiform purpura and macrothrombi presenting as pulmonary thromboembolism in the setting of COVID-19 coagulopathy. From now on, we will have to include COVID-19 infection in the differential diagnosis of retiform purpura. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis cache = ./cache/cord-260218-add4i1c9.txt txt = ./txt/cord-260218-add4i1c9.txt === reduce.pl bib === id = cord-283716-tleh9323 author = Amatore, F. title = SARS‐CoV‐2 infection presenting as a febrile rash date = 2020-05-27 pages = extension = .txt mime = text/plain words = 828 sentences = 53 flesch = 48 summary = The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide.1 After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide. 1 After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. [3] [4] [5] [6] [7] [8] [9] Herein, we describe a febrile rash as the only clinical manifestation of SARS-CoV-2 infection in a patient free from pulmonary symptoms. Firstly, Covid-19 disease can present with a distinctive rash, which is histologically similar but clinically different to classic viral exanthemata. cache = ./cache/cord-283716-tleh9323.txt txt = ./txt/cord-283716-tleh9323.txt === reduce.pl bib === id = cord-326737-b6gs9z4h author = Balestri, R. title = STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections date = 2020-07-27 pages = extension = .txt mime = text/plain words = 705 sentences = 44 flesch = 51 summary = title: STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections 2 During the lockdown (9 March -4 May), we diagnosed, by NAATs, 9 Chlamydia trachomatis infections and 2 Neisseria gonorrhoeae infections (one of these patients experienced a reinfection during the lockdown despite a negative-tested partner), and 4 cases of syphilis (Table 1) . Of these 15 STIs, 9 patients referred risky sexual behaviour during lockdown. Common sense suggests that social isolation and the closure of leisure venues may significantly reduce the opportunity for casual sexual encounters, and some authors suggested that quarantine and social distancing measures might reduce the incidence of STIs in the future. 4 Therefore, we suggest that visits of STI patients should not be cancelled, making use of teledermatology where possible and visiting any doubtful cases. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China The impacts of isolation measures against SARS-CoV-2 infection on sexual health cache = ./cache/cord-326737-b6gs9z4h.txt txt = ./txt/cord-326737-b6gs9z4h.txt === reduce.pl bib === === reduce.pl bib === id = cord-282653-9n5sjn23 author = Rodríguez‐Jiménez, Pedro title = Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection”: Urticaria‐like lesions in COVID‐19 patients are not really urticaria. A case with clinicopathologic correlation date = 2020-05-09 pages = extension = .txt mime = text/plain words = 684 sentences = 52 flesch = 56 summary = key: cord-282653-9n5sjn23 considering urticarial lesions as a coronavirus disease 2019 (COVID‐19) associated skin manifestation(1). considering urticarial lesions as a coronavirus disease 2019 (COVID-19) associated skin manifestation 1 . A previous report of COVID19-related urticarial lesions had also been first published by Recalcati 2 . Since then, we began to observe different skin manifestations in patients with COVID-19 infection. We present the case of a patient with non-evanescent urticarial lesions and its clinicopathologic correlation. In our experience, these urticaria-like lesions may also appear in late phases and not only as early manifestations of COVID. But we must remember, that even today, when it seems that all of our patients are affected of COVID-19 and all the skin diseases may be related to it, we have to ground on clinicopathological correlation and to maintain the same quality standards that we used to have before SARS-Cov-2 appeared. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients cache = ./cache/cord-282653-9n5sjn23.txt txt = ./txt/cord-282653-9n5sjn23.txt === reduce.pl bib === === reduce.pl bib === id = cord-309507-oe4i6v5x author = Sacchelli, L. title = Sexually Transmitted Infections during the COVID‐19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice date = 2020-06-03 pages = extension = .txt mime = text/plain words = 888 sentences = 54 flesch = 54 summary = Sexually transmitted infections (STIs) and diseases (STDs) affect millions of people every year worldwide(1). All rights reserved To the Editor, Sexually transmitted infections (STIs) and diseases (STDs) affect millions of people every year worldwide 1 . In Italy, data are provided by the Italian National Institute of Health (INIH) and reported to the European Centre for Disease Prevention and Control (ECDC) 2, 3 . In Italy, data are provided by the Italian National Institute of Health (INIH) and reported to the European Centre for Disease Prevention and Control (ECDC) 2, 3 . A total of 214 medical provisions were recorded after the lockdown: 13 patients required more than one healthcare service. The percentage of visits for prophylaxis declined after the lockdown, while visits for syphilis, gonococcal pharyngitis and inflammatory genital diseases increased significantly (Figure 1) . The percentage of patients requiring more than one provision increased from 2.1% to 6.5%, after the lockdown. cache = ./cache/cord-309507-oe4i6v5x.txt txt = ./txt/cord-309507-oe4i6v5x.txt === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === id = cord-339195-aq3hb68r author = Falkenhain‐López, D. title = COVID‐19‐related acute genital ulcers date = 2020-06-26 pages = extension = .txt mime = text/plain words = 848 sentences = 63 flesch = 47 summary = A wide variety of cutaneous manifestations has recently been reported as COVID-19-related skin lesions, such as erythematous rash, acro-ischemia or chilblain-like lesions 1, 2 , which can be useful for the clinical diagnosis of COVID-19. Dear editor, A wide variety of cutaneous manifestations has recently been reported as COVID-19-related skin lesions, such as erythematous rash, acro-ischaemia or chilblain-like lesions, 1,2 which can be useful for the clinical diagnosis of COVID-19. In order to report a new clinical manifestation of SARS Coronavirus 2, we present a case of acute reactive genital ulcers in a COVID-19 patient. In order to report a new clinical manifestation of SARS Coronavirus 2, we present a case of acute reactive genital ulcers in a COVID-19 patient. One week later, the patient returned to our department referring improvement of the genital ulcers with pain reduction and complete resolution of the oral aphtha. cache = ./cache/cord-339195-aq3hb68r.txt txt = ./txt/cord-339195-aq3hb68r.txt === reduce.pl bib === === reduce.pl bib === id = cord-327036-0260rrdx author = Dominguez‐Santas, M. title = Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19) date = 2020-05-26 pages = extension = .txt mime = text/plain words = 411 sentences = 33 flesch = 53 summary = title: Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19) The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has rapidly become a global health issue. This letter reports new dermatologic findings associated with a confirmed COVID‐19 case. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global health issue. This letter reports new dermatologic findings associated with a confirmed COVID-19 case. Although the rRT-PCR from skin biopsy was negative, we believe that CSVV arising in the context of a COVID-19 infected person is no coincidence and should not be categorized as idiopathic. There are numerous reports of viral-induced vasculitis, either associated with cryoglobulin presence (as in HCV infected patients) 4 , or unrelated to them (as in individuals with influenza-vaccine-induced vasculitis) 5 . Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients cache = ./cache/cord-327036-0260rrdx.txt txt = ./txt/cord-327036-0260rrdx.txt === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === id = cord-341999-nosdj7b2 author = Conti, A. title = Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs date = 2020-05-07 pages = extension = .txt mime = text/plain words = 601 sentences = 32 flesch = 45 summary = Since December 2019, the pandemic coronavirus disease (2019‐nCoV; COVID‐19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1). However, few reports are available on the course of COVID‐19 infection in psoriatic patients treated with biological drugs (2). Since December 2019, the pandemic coronavirus disease (2019-nCoV; COVID-19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1) . However, few reports are available on the course of COVID-19 infection in psoriatic patients treated with biological drugs (2) . We describe a case series of four psoriatic patients treated with biologics who had a risk contact with COVID-19. cache = ./cache/cord-341999-nosdj7b2.txt txt = ./txt/cord-341999-nosdj7b2.txt === reduce.pl bib === === reduce.pl bib === id = cord-267748-uzt8a5nx author = Shiohara, Tetsuo title = Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 date = 2020-09-24 pages = extension = .txt mime = text/plain words = 920 sentences = 51 flesch = 37 summary = title: Comment on "Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19": Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DiHS), in a COVID-19 patient: 1 the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine. Indeed, diverse clinical symptoms in DiHS/DRESS have been also reported as COVID-19-related cutaneous manifestations without confirming viral or drug etiologies: they include erythema multiforme, varicella, herpes zoster, pityriasis rosea, Kawasaki disease and urticaria, 5~7 in which herpesviruses, such as varicella-zoster virus (VZV) and human herpesvirus 6 (HHV-6), have been suggested to play a role. cache = ./cache/cord-267748-uzt8a5nx.txt txt = ./txt/cord-267748-uzt8a5nx.txt === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === === reduce.pl bib === ===== Reducing email addresses Creating transaction Updating adr table ===== Reducing keywords cord-266475-t04pukea cord-258581-46p0k9lc cord-260218-add4i1c9 cord-283716-tleh9323 cord-326737-b6gs9z4h cord-252123-z8c14q5d cord-309507-oe4i6v5x cord-282653-9n5sjn23 cord-301483-dsaltzdd cord-295551-ujnks5ox cord-272321-znnipzym cord-270500-5pkx94zu cord-310841-scg0h40b cord-341118-h5t87vf8 cord-344273-uztk6pc0 cord-311523-erntrh3p cord-323334-ie7iklr4 cord-303514-2ljmkabk cord-342254-vdovpfu1 cord-346763-xdfl659q cord-345514-71qgingu cord-304211-5uzqqbr4 cord-314422-u2elzgl8 cord-290146-7fz9bj0b cord-341999-nosdj7b2 cord-340842-s00465sy cord-282750-d9sb7o63 cord-327036-0260rrdx cord-281703-6xwcxe8l cord-277110-e27lm7rr cord-267748-uzt8a5nx cord-346017-wforwxes cord-253552-qreg4emx cord-299143-vcfu79ij cord-300995-tqz2bkdo cord-304946-fs02dxg5 cord-339195-aq3hb68r cord-300546-s29ycc8i cord-322069-ys9s7l6e Creating transaction Updating wrd table ===== Reducing urls Creating transaction Updating url table ===== Reducing named entities cord-266475-t04pukea cord-260218-add4i1c9 cord-309507-oe4i6v5x cord-277110-e27lm7rr cord-301483-dsaltzdd cord-258581-46p0k9lc cord-282653-9n5sjn23 cord-283716-tleh9323 cord-295551-ujnks5ox cord-252123-z8c14q5d cord-326737-b6gs9z4h cord-272321-znnipzym cord-339195-aq3hb68r cord-310841-scg0h40b cord-341118-h5t87vf8 cord-270500-5pkx94zu cord-300995-tqz2bkdo cord-304211-5uzqqbr4 cord-299143-vcfu79ij cord-282750-d9sb7o63 cord-304946-fs02dxg5 cord-311523-erntrh3p cord-303514-2ljmkabk cord-323334-ie7iklr4 cord-342254-vdovpfu1 cord-327036-0260rrdx cord-344273-uztk6pc0 cord-314422-u2elzgl8 cord-281703-6xwcxe8l cord-341999-nosdj7b2 cord-346017-wforwxes cord-345514-71qgingu cord-290146-7fz9bj0b cord-346763-xdfl659q cord-322069-ys9s7l6e cord-340842-s00465sy cord-300546-s29ycc8i cord-253552-qreg4emx cord-267748-uzt8a5nx Creating transaction Updating ent table ===== Reducing parts of speech cord-266475-t04pukea cord-260218-add4i1c9 cord-258581-46p0k9lc cord-326737-b6gs9z4h cord-252123-z8c14q5d cord-283716-tleh9323 cord-282653-9n5sjn23 cord-277110-e27lm7rr cord-301483-dsaltzdd cord-309507-oe4i6v5x cord-295551-ujnks5ox cord-272321-znnipzym cord-310841-scg0h40b cord-339195-aq3hb68r cord-304946-fs02dxg5 cord-304211-5uzqqbr4 cord-299143-vcfu79ij cord-342254-vdovpfu1 cord-253552-qreg4emx cord-303514-2ljmkabk cord-311523-erntrh3p cord-281703-6xwcxe8l cord-270500-5pkx94zu cord-344273-uztk6pc0 cord-341118-h5t87vf8 cord-300995-tqz2bkdo cord-327036-0260rrdx cord-282750-d9sb7o63 cord-314422-u2elzgl8 cord-290146-7fz9bj0b cord-346763-xdfl659q cord-345514-71qgingu cord-346017-wforwxes cord-341999-nosdj7b2 cord-323334-ie7iklr4 cord-340842-s00465sy cord-300546-s29ycc8i cord-322069-ys9s7l6e cord-267748-uzt8a5nx Creating transaction Updating pos table Building ./etc/reader.txt cord-277110-e27lm7rr cord-311523-erntrh3p cord-304946-fs02dxg5 cord-311523-erntrh3p cord-277110-e27lm7rr cord-340842-s00465sy number of items: 39 sum of words: 6,890 average size in words: 689 average readability score: 48 nouns: patients; skin; infection; lesions; patient; case; manifestations; disease; cases; article; coronavirus; pandemic; symptoms; copyright; rights; days; treatment; authors; risk; syndrome; study; drug; virus; infections; health; care; date; time; lockdown; journal; diseases; title; pneumonia; doi; rash; drugs; number; management; diagnosis; cord_uid; reaction; dermatitis; children; fever; therapy; response; outbreak; age; urticaria; report verbs: reported; protected; reserved; included; presented; associated; observed; described; showed; developed; caused; affected; used; performed; inducing; considered; suggested; require; related; increase; led; given; found; infected; confirmed; known; involving; identified; written; tested; taken; referred; started; spread; seems; provides; needed; made; become; treated; following; based; disclose; support; preventing; covid-19; compared; appeared; revealed; remain adjectives: covid-19; cutaneous; clinical; severe; acute; viral; respiratory; inflammatory; like; new; first; medical; negative; systemic; positive; immunosuppressive; possible; novel; vascular; immune; acral; similar; normal; non; due; common; many; key; different; mild; general; dermatological; autoimmune; asymptomatic; recent; informed; important; anti; old; italian; higher; early; chronic; young; specific; social; pulmonary; psoriatic; primary; last adverbs: also; however; well; therefore; potentially; even; currently; mainly; recently; especially; later; worldwide; moreover; first; sexually; now; already; completely; still; often; previously; never; less; initially; highly; furthermore; finally; better; significantly; far; directly; respectively; prior; particularly; interestingly; indeed; clinically; approximately; yet; usually; unfortunately; specifically; rapidly; otherwise; long; instead; importantly; frequently; typically; strongly pronouns: we; our; it; their; she; they; its; them; us; her; his; he; i; itself; you; themselves; theirs; mg; lesions,6; him; cord-344273-uztk6pc0 proper nouns: COVID-19; SARS; CoV-2; COVID‐19; Italy; March; Venereol; J; Eur; Dermatol; Acad; Coronavirus; sha; China; PCR; Fig; Wuhan; SARS‐CoV‐2; Disease; mg; M.; Hospital; Article; ICU; Spain; Health; Dr.; April; Accepted; AR; pemphigus; Urticaria; RT; Dermatology; COVID; C.; RNA; COVID19; CAG; •; MERS; L.; December; C; B19; S.; F.; Covid-19; azithromycin; apremilast keywords: covid-19; sars; patient; italy; disease; urticaria; ulcer; sti; skin; rog; mask; march; manifestation; lesion; immunosuppressive; emergency; dress; chilblain one topic; one dimension: covid file(s): https://www.ncbi.nlm.nih.gov/pubmed/32455499/ titles(s): Late onset of acral necrosis after SARS‐CoV‐2 infection resolution three topics; one dimension: covid; patients; covid file(s): https://doi.org/10.1111/jdv.16515, https://doi.org/10.1111/jdv.16956, https://doi.org/10.1111/jdv.16838 titles(s): Dermatologists and SARS‐CoV‐2: The impact of the pandemic on daily practice | Androgen Receptor Genetic Variant Predicts COVID‐19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID‐19 Male Patients | Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19 five topics; three dimensions: covid patients infection; covid patients cov; covid drug skin; covid patients cutaneous; patients covid emergency file(s): https://doi.org/10.1111/jdv.16515, https://doi.org/10.1111/jdv.16751, https://doi.org/10.1111/jdv.16838, https://doi.org/10.1111/jdv.16956, https://doi.org/10.1111/jdv.16473 titles(s): Dermatologists and SARS‐CoV‐2: The impact of the pandemic on daily practice | Major cluster of pediatric “ true ” primary chilblains during the COVID‐19 pandemic: a consequence of lifestyle changes due to lockdown | Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19 | Androgen Receptor Genetic Variant Predicts COVID‐19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID‐19 Male Patients | Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) Type: cord title: journal-jEurAcadDermatolVenereol-cord date: 2021-05-30 time: 15:05 username: emorgan patron: Eric Morgan email: emorgan@nd.edu input: facet_journal:"J Eur Acad Dermatol Venereol" ==== make-pages.sh htm files ==== make-pages.sh complex files ==== make-pages.sh named enities ==== making bibliographics id: cord-283716-tleh9323 author: Amatore, F. title: SARS‐CoV‐2 infection presenting as a febrile rash date: 2020-05-27 words: 828.0 sentences: 53.0 pages: flesch: 48.0 cache: ./cache/cord-283716-tleh9323.txt txt: ./txt/cord-283716-tleh9323.txt summary: The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide.1 After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide. 1 After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. [3] [4] [5] [6] [7] [8] [9] Herein, we describe a febrile rash as the only clinical manifestation of SARS-CoV-2 infection in a patient free from pulmonary symptoms. Firstly, Covid-19 disease can present with a distinctive rash, which is histologically similar but clinically different to classic viral exanthemata. abstract: The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide.1 After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. url: https://doi.org/10.1111/jdv.16528 doi: 10.1111/jdv.16528 id: cord-310841-scg0h40b author: Atzori, L. title: Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) date: 2020-04-15 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Psoriasis is a major chronic inflammatory skin disease, affecting about 3% of the population in Italy, whose management require experienced specialists in order to guarantee high‐quality standards of care. The pandemic coronavirus (2019‐nCoV; COVID‐19) has changed the approach to all patients requiring close contact during a visit, including dermatologic consultations. In Italy, true outbreak begun in Lombardy, by February 21, 2020 with exponential contagion, surpassing China in the number of deaths. url: https://doi.org/10.1111/jdv.16473 doi: 10.1111/jdv.16473 id: cord-266475-t04pukea author: Balestri, R. title: Late onset of acral necrosis after SARS‐CoV‐2 infection resolution date: 2020-05-26 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: SARS‐CoV‐2 has been hypothesized as the aetiologic agent of CLL, on the basis of the temporal correlation between the “burst” of skin manifestations and the viral pandemic, even though we have scarce evidence of swab‐confirmed infections. Authors have therefore suggested some pathogenetic mechanisms such as a delayed immune‐mediated reaction to the virus in genetically‐predisposed patients(1) or an early IFN‐I response in young patients, muting early viral replication but also inducing microangiopathic changes. url: https://www.ncbi.nlm.nih.gov/pubmed/32455499/ doi: 10.1111/jdv.16668 id: cord-300546-s29ycc8i author: Balestri, R. title: Occurrence of SARS‐CoV‐2 during mycophenolate mofetil treatment for pemphigus date: 2020-05-02 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: we read with great interest the article entitled “Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases?” published by Di Altobrando A. et al. in the JEADV. This is the first report of COronaVIrus DIsease 2019 (COVID‐19) in a patient affected by autoimmune blistering disease (ABD) during immunosuppressive treatment (i.e. azathioprine). The authors conclude that it is crucial to learn of more cases of ABD patients under immunosuppressive treatment who have developed COVID‐19, in order to better quantify the risk of infection under immunosuppressive therapy. url: https://www.ncbi.nlm.nih.gov/pubmed/32359182/ doi: 10.1111/jdv.16578 id: cord-326737-b6gs9z4h author: Balestri, R. title: STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections date: 2020-07-27 words: 705.0 sentences: 44.0 pages: flesch: 51.0 cache: ./cache/cord-326737-b6gs9z4h.txt txt: ./txt/cord-326737-b6gs9z4h.txt summary: title: STIs and the COVID‐19 pandemic: the lockdown does not stop sexual infections 2 During the lockdown (9 March -4 May), we diagnosed, by NAATs, 9 Chlamydia trachomatis infections and 2 Neisseria gonorrhoeae infections (one of these patients experienced a reinfection during the lockdown despite a negative-tested partner), and 4 cases of syphilis (Table 1) . Of these 15 STIs, 9 patients referred risky sexual behaviour during lockdown. Common sense suggests that social isolation and the closure of leisure venues may significantly reduce the opportunity for casual sexual encounters, and some authors suggested that quarantine and social distancing measures might reduce the incidence of STIs in the future. 4 Therefore, we suggest that visits of STI patients should not be cancelled, making use of teledermatology where possible and visiting any doubtful cases. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China The impacts of isolation measures against SARS-CoV-2 infection on sexual health abstract: In December 2019 a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China, responsible for an aggressive interstitial pneumonia. Italy was the first western country to be hit by the CoronaVIrus Disease 2019 (COVID-19) and on 9 March our Prime Minister announced a nationwide lockdown, strictly forbidding any contacts outside cohabitants, except for urgent or medical reasons. In compliance with the ministerial decree, all scheduled visits were suspended, maintaining hospital access only for emergencies. url: https://doi.org/10.1111/jdv.16808 doi: 10.1111/jdv.16808 id: cord-282750-d9sb7o63 author: Benhadou, F. title: Improvement of SARS‐CoV2 symptoms following Guselkumab injection in a psoriatic patient date: 2020-05-07 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: We read with great interest the publication of Messina et al (1) reporting the first case of SARS‐CoV2 infection in a young patient of 32‐year‐old suffering from psoriasis and psoriatic arthritis treated by Guselkumab, a monoclonal antibody that targets specifically the p19 subunit of Interleukin (IL)‐23(2).The patient contracted the SARS‐CoV2 infection after a dinner with some friends but fortunately she developed very discrete symptoms including only mild fever and rhinorrhea. These findings support the potential role of IL‐23p19 inhibitors to counteract the « cytokine storm » triggered by the SARS‐CoV2 and which is potentially implicated in the severity of the symptoms (3). url: https://www.ncbi.nlm.nih.gov/pubmed/32379925/ doi: 10.1111/jdv.16590 id: cord-258581-46p0k9lc author: Bodak, Nathalie title: COVID‐19 Lockdown induced acral dermatosis in children date: 2020-06-28 words: 557.0 sentences: 36.0 pages: flesch: 55.0 cache: ./cache/cord-258581-46p0k9lc.txt txt: ./txt/cord-258581-46p0k9lc.txt summary: Recently, several case series of cutaneous acral manifestations in patients with suspected or confirmed coronavirus disease 2019 (COVID‐19) have been reported. Indirect consequences of the ongoing pandemic on skin health have been reported, such as an increased frequency of irritant dermatitis related to repeated hand washing with soap, or occupational dermatoses in health care workers due to wearing gloves or masks (4, 5) . We describe here acral lesions observed in seven children (four girls) by the sixth week of the lockdown period in France. Although a larger case series would strengthen our hypothesis, we suggest that the change of daily habits in young children during the lockdown period may have increased the frequency of acral frictional dermatoses that are not directly due to the virus but rather to prolonged sessions spent playing on the floor. Acral cutaneous lesions in the Time of COVID-19 abstract: Recently, several case series of cutaneous acral manifestations in patients with suspected or confirmed coronavirus disease 2019 (COVID‐19) have been reported. A majority of these acral manifestations have a pseudo‐chilblain pattern with erythema and oedema and sometimes vesicles. url: https://doi.org/10.1111/jdv.16797 doi: 10.1111/jdv.16797 id: cord-260218-add4i1c9 author: Bosch‐Amate, X title: Retiform purpura as a dermatological sign of covid‐19 coagulopathy date: 2020-06-03 words: 448.0 sentences: 36.0 pages: flesch: 43.0 cache: ./cache/cord-260218-add4i1c9.txt txt: ./txt/cord-260218-add4i1c9.txt summary: Recalcati(1) asserted that 20.4% of infected patients developed cutaneous manifestations and Galván‐Casas et al(2) have recently proposed 5 clinical patterns (pseudo‐chilblain, vesicular, urticarial, maculopapular and livedo/necrosis). 6 Purpura, Raynaud''s phenomenon, chilblain-like and erythema multiforme-like lesions in young asymptomatic patients have also been observed with this infection, although the connection with coagulopathy is unknown. 7, 8 Our patient presented with retiform purpura as a cutaneous manifestation of COVID-19 coagulopathy. 9 Our case highlights the concomitant presentation of cutaneous microthrombi presenting as retiform purpura and macrothrombi presenting as pulmonary thromboembolism in the setting of COVID-19 coagulopathy. From now on, we will have to include COVID-19 infection in the differential diagnosis of retiform purpura. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis abstract: Since December 2019, coronavirus disease 2019 (COVID‐19) has spread worldwide to become a pandemic. Multiple skin manifestations related to the infection have been described progressively. Recalcati(1) asserted that 20.4% of infected patients developed cutaneous manifestations and Galván‐Casas et al(2) have recently proposed 5 clinical patterns (pseudo‐chilblain, vesicular, urticarial, maculopapular and livedo/necrosis). We report a case of COVID‐19 with retiform purpura and its histopathological correlation. url: https://www.ncbi.nlm.nih.gov/pubmed/32491234/ doi: 10.1111/jdv.16689 id: cord-314422-u2elzgl8 author: Bothra, Atul title: Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic date: 2020-06-03 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: The COVID‐19 pandemic forged theexponential use of masks of various kinds, not just by health workers but also by general population as a personal protective equipment (PPE). Although contact dermatitis due to PPE is well reported, mask induced dermatitis is a relatively unexplored phenomenon. In this article, we report a preliminary data of patients experiencing retroauricaular dermatitis due to ear loop face masks. url: https://doi.org/10.1111/jdv.16692 doi: 10.1111/jdv.16692 id: cord-253552-qreg4emx author: Bouaziz, JD title: Vascular skin symptoms in COVID‐19: a french observational study date: 2020-04-27 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Coronavirus 19 (COVID‐19) was declared as a pandemic viral infection by the World Health organization on March 11(th) 2020. Usual clinical manifestations of COVID‐19 infection include fever, fatigue, myalgia, headache, diarrhea, dry cough, dyspnea that may lead to acute respiratory distress syndrome and death (1). Skin symptoms of COVID‐19 have been poorly described but may include erythematous rash, urticaria and chicken pox like lesions (2‐7). Angiotensin‐converting enzyme 2 (ACE2) is a cellular receptor for COVID‐19. url: https://www.ncbi.nlm.nih.gov/pubmed/32339344/ doi: 10.1111/jdv.16544 id: cord-304946-fs02dxg5 author: Brochez, L. title: Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic date: 2020-08-12 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: nan url: https://www.ncbi.nlm.nih.gov/pubmed/32789960/ doi: 10.1111/jdv.16772 id: cord-340842-s00465sy author: Cabrera‐Hernández, R. title: SARS‐CoV‐2, skin lesions and the need of a multidisciplinary approach date: 2020-06-13 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: COVID‐19 is a disease caused by severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus (SARS‐CoV‐2). It was first described in Wuhan (China) on December 2019 and has spread to become a pandemic. Its clinical presentation is mainly characterized by cough, fever and dyspnea, although many other symptoms have been described within its presentation pattern. In some cases, it causes an acute respiratory distress that has lead to the death of thousands of people around the world. Furthermore, different types of skin lesions have been described during the infection period of illness.1 In this exceptional situation of global health emergency, physicians are undertaking research work in order to achieve notions on the etiopathogenesis of these skin lesions. The first report of cutaneous manifestations described different forms of skin lesions such as erythematous rash, urticaria and chicken‐pox‐like vesicles.2 Further studies have classified 5 different type of skin lesions, and associated them with patient demographics, timing in relation to symptoms of the disease, severity and prognosis. url: https://doi.org/10.1111/jdv.16745 doi: 10.1111/jdv.16745 id: cord-341999-nosdj7b2 author: Conti, A. title: Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs date: 2020-05-07 words: 601.0 sentences: 32.0 pages: flesch: 45.0 cache: ./cache/cord-341999-nosdj7b2.txt txt: ./txt/cord-341999-nosdj7b2.txt summary: Since December 2019, the pandemic coronavirus disease (2019‐nCoV; COVID‐19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1). However, few reports are available on the course of COVID‐19 infection in psoriatic patients treated with biological drugs (2). Since December 2019, the pandemic coronavirus disease (2019-nCoV; COVID-19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1) . However, few reports are available on the course of COVID-19 infection in psoriatic patients treated with biological drugs (2) . We describe a case series of four psoriatic patients treated with biologics who had a risk contact with COVID-19. abstract: Since December 2019, the pandemic coronavirus disease (2019‐nCoV; COVID‐19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1). However, few reports are available on the course of COVID‐19 infection in psoriatic patients treated with biological drugs (2). We describe a case series of four psoriatic patients treated with biologics who had a risk contact with COVID‐19. url: https://doi.org/10.1111/jdv.16587 doi: 10.1111/jdv.16587 id: cord-281703-6xwcxe8l author: Di Altobrando, Ambra title: Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases? date: 2020-04-17 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID‐19), scientific data relating to the causative virus SARS‐CoV‐2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner. url: https://www.ncbi.nlm.nih.gov/pubmed/32302437/ doi: 10.1111/jdv.16491 id: cord-327036-0260rrdx author: Dominguez‐Santas, M. title: Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19) date: 2020-05-26 words: 411.0 sentences: 33.0 pages: flesch: 53.0 cache: ./cache/cord-327036-0260rrdx.txt txt: ./txt/cord-327036-0260rrdx.txt summary: title: Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19) The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has rapidly become a global health issue. This letter reports new dermatologic findings associated with a confirmed COVID‐19 case. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global health issue. This letter reports new dermatologic findings associated with a confirmed COVID-19 case. Although the rRT-PCR from skin biopsy was negative, we believe that CSVV arising in the context of a COVID-19 infected person is no coincidence and should not be categorized as idiopathic. There are numerous reports of viral-induced vasculitis, either associated with cryoglobulin presence (as in HCV infected patients) 4 , or unrelated to them (as in individuals with influenza-vaccine-induced vasculitis) 5 . Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients abstract: The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has rapidly become a global health issue. Although it is known to produce diverse cutaneous manifestations, some of them have yet to be described. This letter reports new dermatologic findings associated with a confirmed COVID‐19 case. url: https://www.ncbi.nlm.nih.gov/pubmed/32453865/ doi: 10.1111/jdv.16663 id: cord-270500-5pkx94zu author: Duong, T.A. title: Did Whatsapp(®) reveal a new cutaneous COVID‐19 manifestation? date: 2020-05-19 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: In March 2020, Europe became the epicenter of COVID-19 pandemic. Several countries organized nationwide population containment, starting on March 9th in Italy and March 17th in France1 . For the continuity of care and to avoid in person consultation and disease propagation, the French ministry of health released incentives to facilitate live interactive consultation for COVID and non-COVID patients. url: https://doi.org/10.1111/jdv.16534 doi: 10.1111/jdv.16534 id: cord-295551-ujnks5ox author: Estébanez, Andrea title: Cutaneous manifestations in COVID‐19: a new contribution date: 2020-04-15 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: We have read with great interest Dr Recalcati’s review about skin manifestations in COVID‐19 as it is the first report on this subject(1). In a recent review on clinical characteristics of coronavirus disease 2019 in China, rash was observed in 0,2% of cases(2). However, from the trained eyes of a dermatologist, this percentage may be higher. url: https://www.ncbi.nlm.nih.gov/pubmed/32294264/ doi: 10.1111/jdv.16474 id: cord-339195-aq3hb68r author: Falkenhain‐López, D. title: COVID‐19‐related acute genital ulcers date: 2020-06-26 words: 848.0 sentences: 63.0 pages: flesch: 47.0 cache: ./cache/cord-339195-aq3hb68r.txt txt: ./txt/cord-339195-aq3hb68r.txt summary: A wide variety of cutaneous manifestations has recently been reported as COVID-19-related skin lesions, such as erythematous rash, acro-ischemia or chilblain-like lesions 1, 2 , which can be useful for the clinical diagnosis of COVID-19. Dear editor, A wide variety of cutaneous manifestations has recently been reported as COVID-19-related skin lesions, such as erythematous rash, acro-ischaemia or chilblain-like lesions, 1,2 which can be useful for the clinical diagnosis of COVID-19. In order to report a new clinical manifestation of SARS Coronavirus 2, we present a case of acute reactive genital ulcers in a COVID-19 patient. In order to report a new clinical manifestation of SARS Coronavirus 2, we present a case of acute reactive genital ulcers in a COVID-19 patient. One week later, the patient returned to our department referring improvement of the genital ulcers with pain reduction and complete resolution of the oral aphtha. abstract: A wide variety of cutaneous manifestations has recently been reported as COVID-19-related skin lesions, such as erythematous rash, acro-ischemia or chilblain-like lesions 1, 2 , which can be useful for the clinical diagnosis of COVID-19. Case reports of other less frequent COVID-19-related skin disorders such as pytiriasis rosea 3 or livedo reticularis 4 have been also described. In order to report a new clinical manifestation of SARS-Coronavirus-2, we present a case of acute reactive genital ulcers in a COVID-19 patient. url: https://www.ncbi.nlm.nih.gov/pubmed/32534473/ doi: 10.1111/jdv.16740 id: cord-322069-ys9s7l6e author: Gaspari, Valeria title: COVID‐19: how it can look on the skin. Clinical and pathological features in twenty COVID‐19 patients observed in Bologna, northeastern Italy date: 2020-06-03 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Global public health is currently dealing with the explosive spread of the novel Coronavirus disease 2019 (COVID‐19) [1]. This new type of viral pneumonia, spread from its first focus in Wuhan (Hubei, China) to across all the world, until a pandemic condition was declared. Clinically. the most common symptoms of the disease are cough and fever. More than 80% of patients have asymptomatic to moderate disease, but about 15% get severe pneumonia and 5% develope a multi‐organ failure [2]. url: https://www.ncbi.nlm.nih.gov/pubmed/32491223/ doi: 10.1111/jdv.16693 id: cord-311523-erntrh3p author: Gisondi, P title: Dermatologists and SARS‐CoV‐2: The impact of the pandemic on daily practice date: 2020-04-22 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Since the first case of “pneumonia of unknown aetiology” was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as “severe acute respiratory syndrome coronavirus 2” (SARS‐CoV‐2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease‐19 (COVID‐ 19) and satisfying the epidemiological criteria for a label of “pandemic.” The ongoing SARS‐CoV‐2 pandemic is having a huge impact on dermatological practice including the marked reduction of face‐to‐face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID‐19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID‐19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS‐CoV‐2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS‐CoV‐2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS‐CoV‐2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID‐19 disaster. Learning from experience may help to cope with future major societal changes. url: https://doi.org/10.1111/jdv.16515 doi: 10.1111/jdv.16515 id: cord-301483-dsaltzdd author: Hashizume, H. title: Eosinophilic granulomatosis with polyangiitis mimicking COVID‐19: a case report date: 2020-06-04 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, is currently spreading worldwide, causing the worst pandemic experienced this century. During the present outbreak, reports have been accumulating that various types of cutaneous manifestations were observed in COVID‐19 patients. We read with interest the recent article by Amatore et al. describing a COVID‐19 case who presented with a febrile rash consisting of annular, polycyclic, and circinate erythema, presumably specific to COVID‐19. url: https://www.ncbi.nlm.nih.gov/pubmed/32495957/ doi: 10.1111/jdv.16705 id: cord-346763-xdfl659q author: Herman, A. title: Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19 date: 2020-08-13 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Skin rashes associated with COVID-19 include eruptions induced by drugs prescribed for management of this infection. We report a case of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with COVID-19. A 50-year-old man was admitted to the intensive care unit for pneumonia with acute respiratory distress syndrome. COVID-19 was confirmed by positive RT-PCR SARS-CoV-2 on nasopharyngeal swabs and later by positive IgM and IgG antibodies against SARS-CoV-2 (114,5 AU/mL). In the context of fever >38,5°C, nine days after admission, the patient developed a generalized maculopapular rash on more than 70% of his body surface area with oedema of hands and face (Fig.1). Azithromycin and hydroxychloroquine had been initiated 18 and 17 days respectively prior to the skin eruption. url: https://doi.org/10.1111/jdv.16838 doi: 10.1111/jdv.16838 id: cord-277110-e27lm7rr author: Iria, Neri title: Major cluster of pediatric “ true ” primary chilblains during the COVID‐19 pandemic: a consequence of lifestyle changes due to lockdown date: 2020-06-13 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: BACKGROUND: Over the last months, during the COVID‐19 pandemic, a growing number of chilblain‐like lesions was reported mainly in children, rarely in young adults. The relationship with SARS‐CoV‐2 infection was postulated, often without any laboratory, instrumental or clinical confirmation. The disclosure of information about chilblain‐like lesions as a COVID‐19 manifestation in social media has created concern in children’s families and pediatricians OBJECTIVES: to verify whether the chilblain‐like lesions were caused by SARS‐CoV‐2 infection. METHODS: prospective study on a case series including children who presented with acral lesions at the Pediatric Dermatology Outpatient and Pediatric Emergency Unit of the University of Bologna, from April 1 to April 30, 2020. We reported demographical, laboratory and clinical features, history of close contact with COVID‐19 patients, presence of similar skin lesions in other family members, precipitating and risk factors for chilblain onset. RESULTS: We evaluated 8 patients (5 females, 3 males) aged between 11 and 15 years. We excluded acute or previous SARS‐CoV‐2 infection with RT‐PCR nasopharyngeal swab, serum antibody levels using chemiluminescent immunoassays. Other acute infections causing purpuric lesions at the extremities were negative in all patients. Skin lesion biopsy for histological and immunohistochemical evaluation was made in two cases and was consistent with chilblain. PCR‐assay on skin lesion biopsy for Parvovirus B19, Mycoplasma pneumoniae and SARS‐CoV‐2 was performed in a patient and resulted negative. We identified common precipitating and risk factors: physical (cold and wet extremities, low BMI), cold and wet indoor and outdoor environment, behaviors, habits, lifestyle. We therefore reached a diagnosis of primary chilblains. CONCLUSIONS: During the COVID‐19 pandemic, a “cluster” of primary chilblains developed in predisposed subjects, mainly teenagers, due to to cold exposure in the lockdown period. Laboratory findings support our hypothesis, although it is also possible that an unknown infectious trigger may have contributed to the pathogenesis. url: https://doi.org/10.1111/jdv.16751 doi: 10.1111/jdv.16751 id: cord-346017-wforwxes author: Kasperkiewicz, M. title: Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic date: 2020-04-25 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Autoimmune bullous diseases (AIBDs) are potentially life‐threatening disorders comprising intra‐epidermal/epithelial (pemphigus) and sub‐epidermal/epithelial blistering diseases (pemphigoid and dermatitis herpetiformis). Corticosteroids and non‐steroid immunomodulatory agents are the mainstays of treatment. Treatment can be challenging particularly in pemphigus, mucous membrane pemphigoid, and epidermolysis bullosa acquisita which may require more intense immunosuppressive approaches url: https://doi.org/10.1111/jdv.16525 doi: 10.1111/jdv.16525 id: cord-299143-vcfu79ij author: McCoy, John title: Androgen Receptor Genetic Variant Predicts COVID‐19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID‐19 Male Patients date: 2020-09-25 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Men infected with SARS‐CoV‐2 are more likely to be admitted to the intensive care unit (ICU) compared to women.(1) Previously, we have reported that among hospitalized men with COVID‐19, 79% presented with androgenetic alopecia (AA) compared to 31‐53% that would be expected in a similar aged match population.(2) AA is known to be mediated by variations in the androgen receptor (AR) gene.(3) In addition, the only known promoter of the enzyme implicated in SARS‐CoV‐2 infectivity, TMPRSS2, is regulated by an androgen response element.(4) The polyglutamine repeat (CAG repeat) located in the AR gene is associated with androgen sensitivity and AA.(3) These observations led us to hypothesize that variations in the AR gene may predispose male COVID‐19 patients to increased disease severity. url: https://doi.org/10.1111/jdv.16956 doi: 10.1111/jdv.16956 id: cord-342254-vdovpfu1 author: Mugheddu, C. title: CID‐19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management date: 2020-06-04 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Novel coronavirus 2019 (SARS-CoV2) pandemic has particularly affected Italy, with a profound impact on the therapeutic strategy for complex disorder such as psoriasis, whose extensive skin damage might expose to an increased infective risk compared to the general population. Psoriasis treatment relies on immunosuppression, and although most experts agree that the benefit-to risk-ratio is in favor of maintaining selective biologic therapies, and small molecules such as apremilast, they recommend dismission if severe COVID-19 symptoms occur. url: https://doi.org/10.1111/jdv.16625 doi: 10.1111/jdv.16625 id: cord-345514-71qgingu author: Najafzadeh, Mojgan title: Urticaria (angioedema) and COVID‐ 19 infection date: 2020-06-11 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: The novel coronavirus, otherwise known as COVID‐19 has fast become a major health concern.(1 2) It has been reported that in addition to the conventional respiratory symptoms, patients also display skin manifestations such as Urticaria and angioedema.(3) Here we present a case study of an elderly man who first presented with generalised pruritic hives ranging from 1.5 to 8.0 cm in diameter on the 5(th) of March 2020. The patient was investigated for another differential diagnosis of Urticaria such as parasitic and bacterial infection, for which negative results were found. On the 5th of March 2020 the patient‐reported these symptoms plus general malaise, fatigue, 37.9⁰C temperature and sore throat. Initial biochemical tests showed that the patient presented with low numbers of white blood cells (WBC) (WBC=2.75x10(3)). url: https://www.ncbi.nlm.nih.gov/pubmed/32525251/ doi: 10.1111/jdv.16721 id: cord-252123-z8c14q5d author: Negrini, S. title: An unusual case of bullous hemorrhagic vasculitis in a COVID‐19 patient date: 2020-06-19 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: A novel Coronavirus strain, named “Severe Acute Respiratory Syndrome Coronavirus 2” (SARS‐CoV‐2) was recently identified as the etiological agent of the COronaVIrus Disease 2019 (COVID‐19). Interestingly, a consistent number of COVID‐19‐associated skin manifestations seem to share a certain degree of vascular damage as common pathogenetic mechanism(1). Vascular injury may be due to the direct damage of endothelial cells by the virus or may represents an epiphenomenon of a dysregulated host inflammatory responses triggered by the infection(2). Here, we describe an unprecedented case of leukocytoclastic vasculitis presenting with a hemorrhagic bullous eruption in a patient affected by COVID‐19. url: https://www.ncbi.nlm.nih.gov/pubmed/32558979/ doi: 10.1111/jdv.16760 id: cord-303514-2ljmkabk author: Recalcati, S. title: Acral cutaneous lesions in the time of COVID‐19 date: 2020-05-27 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries. url: https://www.ncbi.nlm.nih.gov/pubmed/32330324/ doi: 10.1111/jdv.16533 id: cord-290146-7fz9bj0b author: Ring, J. title: COVID‐19 and its implications for Dermatology and Venereology date: 2020-05-22 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: nan url: https://www.ncbi.nlm.nih.gov/pubmed/32441430/ doi: 10.1111/jdv.16414 id: cord-282653-9n5sjn23 author: Rodríguez‐Jiménez, Pedro title: Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection”: Urticaria‐like lesions in COVID‐19 patients are not really urticaria. A case with clinicopathologic correlation date: 2020-05-09 words: 684.0 sentences: 52.0 pages: flesch: 56.0 cache: ./cache/cord-282653-9n5sjn23.txt txt: ./txt/cord-282653-9n5sjn23.txt summary: key: cord-282653-9n5sjn23 considering urticarial lesions as a coronavirus disease 2019 (COVID‐19) associated skin manifestation(1). considering urticarial lesions as a coronavirus disease 2019 (COVID-19) associated skin manifestation 1 . A previous report of COVID19-related urticarial lesions had also been first published by Recalcati 2 . Since then, we began to observe different skin manifestations in patients with COVID-19 infection. We present the case of a patient with non-evanescent urticarial lesions and its clinicopathologic correlation. In our experience, these urticaria-like lesions may also appear in late phases and not only as early manifestations of COVID. But we must remember, that even today, when it seems that all of our patients are affected of COVID-19 and all the skin diseases may be related to it, we have to ground on clinicopathological correlation and to maintain the same quality standards that we used to have before SARS-Cov-2 appeared. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients abstract: We have read with great attention the article by Van Damme et al. considering urticarial lesions as a coronavirus disease 2019 (COVID‐19) associated skin manifestation(1). They observed two patients with erythemato‐edematous lesions surrounded by whitish halo, thus similar to hives but without additional data on their evolution(1). A previous report of COVID19‐related urticarial lesions had also been first published by Recalcati(2). However, none of these two published articles detailed if the lesions where evanescent, as it is mandatory for urticaria, nor did a pathological study. url: https://doi.org/10.1111/jdv.16618 doi: 10.1111/jdv.16618 id: cord-309507-oe4i6v5x author: Sacchelli, L. title: Sexually Transmitted Infections during the COVID‐19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice date: 2020-06-03 words: 888.0 sentences: 54.0 pages: flesch: 54.0 cache: ./cache/cord-309507-oe4i6v5x.txt txt: ./txt/cord-309507-oe4i6v5x.txt summary: Sexually transmitted infections (STIs) and diseases (STDs) affect millions of people every year worldwide(1). All rights reserved To the Editor, Sexually transmitted infections (STIs) and diseases (STDs) affect millions of people every year worldwide 1 . In Italy, data are provided by the Italian National Institute of Health (INIH) and reported to the European Centre for Disease Prevention and Control (ECDC) 2, 3 . In Italy, data are provided by the Italian National Institute of Health (INIH) and reported to the European Centre for Disease Prevention and Control (ECDC) 2, 3 . A total of 214 medical provisions were recorded after the lockdown: 13 patients required more than one healthcare service. The percentage of visits for prophylaxis declined after the lockdown, while visits for syphilis, gonococcal pharyngitis and inflammatory genital diseases increased significantly (Figure 1) . The percentage of patients requiring more than one provision increased from 2.1% to 6.5%, after the lockdown. abstract: Sexually transmitted infections (STIs) and diseases (STDs) affect millions of people every year worldwide(1). In Italy, data are provided by the Italian National Institute of Health (INIH) and reported to the European Centre for Disease Prevention and Control (ECDC)(2,3). In 1991 and 2009 the Italian sentinel surveillance system was established, consisting in 25 public centers (12 clinical, 13 laboratories) on the national field for diagnosis, treatment and data transmission to the INIH(4). The STDs service of Dermatology, Bologna belongs to it and is a free‐access service (7.30‐11 am) from Monday to Friday, with a patient flow of 50 patients/day. url: https://www.ncbi.nlm.nih.gov/pubmed/32491214/ doi: 10.1111/jdv.16694 id: cord-267748-uzt8a5nx author: Shiohara, Tetsuo title: Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 date: 2020-09-24 words: 920.0 sentences: 51.0 pages: flesch: 37.0 cache: ./cache/cord-267748-uzt8a5nx.txt txt: ./txt/cord-267748-uzt8a5nx.txt summary: title: Comment on "Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19": Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DiHS), in a COVID-19 patient: 1 the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine. Indeed, diverse clinical symptoms in DiHS/DRESS have been also reported as COVID-19-related cutaneous manifestations without confirming viral or drug etiologies: they include erythema multiforme, varicella, herpes zoster, pityriasis rosea, Kawasaki disease and urticaria, 5~7 in which herpesviruses, such as varicella-zoster virus (VZV) and human herpesvirus 6 (HHV-6), have been suggested to play a role. abstract: We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug‐induced hypersensitivity syndrome (DiHS), in a COVID‐19 patient:(1) the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine. url: https://doi.org/10.1111/jdv.16959 doi: 10.1111/jdv.16959 id: cord-300995-tqz2bkdo author: Tagliaferri, Luca title: Skin cancer triage and management during COVID‐19 pandemic date: 2020-04-25 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: The worldwide medical community is striving to pursue the most appropriate clinical choices in the worst event of pandemic of the modern times [1], with over 1 million patients affected by COVID‐19 (i.e., swab positive patients with or without symptoms) reported so far [1]. In this context, the aim of the ideal management of cancer patients is to achieve the best possible balance between the two different issues to be considered, which include the risk of cancer progression and the risk of infectious disease. url: https://doi.org/10.1111/jdv.16529 doi: 10.1111/jdv.16529 id: cord-304211-5uzqqbr4 author: Tammaro, A. title: Cutaneous manifestations in COVID‐19: the experiences of Barcelona and Rome date: 2020-04-24 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: In December 2019, a new virus called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causing Coronavirus disease 2019 (COVID‐19) emerged in Wuhan, Hubei Province, China. SARS‐CoV‐2 is transmitted through respiratory droplets and object infected with droplets containing the virus. The diagnosis is made employing quantitative reverse transcriptase polymerase chain reaction to identify the viral nucleic acid in respiratory specimens or blood samples. url: https://doi.org/10.1111/jdv.16530 doi: 10.1111/jdv.16530 id: cord-323334-ie7iklr4 author: Tartari, F title: Changes in emergency service access after spread of COVID19 across Italy date: 2020-04-27 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: The Italian National Health System is currently living through some catastrophic days, owing to the rapid spread of COVID‐19 across the country. At the time of writing, our Government has passed emergency laws (March 11, 2020), with a view to preventing widespread viral infection among the population, which may well lead to an increase in the number of people requiring intensive care unit (ICU) hospital treatment. Currently, most of the northern Italian regions are close to saturation point in terms of the number of available ICU inpatient beds. url: https://doi.org/10.1111/jdv.16553 doi: 10.1111/jdv.16553 id: cord-344273-uztk6pc0 author: Tejera‐Vaquerizo, Antonio title: Estimated effect of COVID‐19 lockdown on melanoma thickness and prognosis: a rate of growth model date: 2020-05-02 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: The coronavirus COVID‐19 pandemic, which emerged in Wuhan, China several months ago,(1) has led to large‐scale lockdown in many countries around the world, including Spain. Uncertainty about the duration of these measures led us to consider the potential impact of diagnostic delays due to the paralyzation of certain health procedures and services on the prognosis of patients with melanoma. url: https://www.ncbi.nlm.nih.gov/pubmed/32362041/ doi: 10.1111/jdv.16555 id: cord-341118-h5t87vf8 author: Torres‐Navarro, Ignacio title: A case of cefditoren‐induced Acute Generalized Exanthematous Pustulosis during COVID‐19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue date: 2020-05-26 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: We read with interest the article by Recalcati et al. about the report of cutaneous manifestations in COVID‐19 patients. We would like to highlight that some potentially severe manifestations in these patients are not directly related to the coronavirus but to the medications administered. url: https://www.ncbi.nlm.nih.gov/pubmed/32455478/ doi: 10.1111/jdv.16664 id: cord-272321-znnipzym author: Verheyden, M. title: Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection date: 2020-06-25 words: nan sentences: nan pages: flesch: nan cache: txt: summary: abstract: During the Coronavirus 2019 (COVID‐19) pandemic, several associated skin conditions were reported in infected patients, including; urticaria [1], exanthema [1], erythema multiforme [2], chickenpox‐like vesicles [1], pityriasis rosea [3], herpes simplex reactivation [4], erythema nodosum like Sweet’s syndrome [5], Symmetrical Drug‐Related Intertriginous and Flexural Exanthema [6], petechial rash [7], vasculitic purpura [7], acro‐ischemia/necrosis [8], Kawasaki disease [2] and chilblain lesions [9]. url: https://doi.org/10.1111/jdv.16773 doi: 10.1111/jdv.16773 ==== make-pages.sh questions [ERIC WAS HERE] ==== make-pages.sh search /data-disk/reader-compute/reader-cord/bin/make-pages.sh: line 77: /data-disk/reader-compute/reader-cord/tmp/search.htm: No such file or directory Traceback (most recent call last): File "/data-disk/reader-compute/reader-cord/bin/tsv2htm-search.py", line 51, in with open( TEMPLATE, 'r' ) as handle : htm = handle.read() FileNotFoundError: [Errno 2] No such file or directory: '/data-disk/reader-compute/reader-cord/tmp/search.htm' ==== make-pages.sh topic modeling corpus Zipping study carrel